A V Pogozheva

Author PubWeight™ 9.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Vopr Pitan 2012 0.81
2 [The clinical and experimental research of metabolic effects of shark liver oil]. Vopr Pitan 2007 0.78
3 [Clinical use of flavonoid enriched biologically active food supplements in patients with chronic atrophic gastritis in combination with chronic cholecystitis or bile ducts dyskinesia]. Vopr Pitan 2003 0.78
4 [The effect of diet with the sour-milk product enriched with amaranth on parameters of antioxigen protection at patients with a cardiovascular pathology]. Vopr Pitan 2004 0.77
5 [The effect of an antiatherosclerotic diet including omega-3 polyunsaturated fatty acids of marine and plant origins on the indices of cellular and humoral immunity in patients with ischemic heart disease and a disordered carbohydrate tolerance]. Vopr Pitan 2000 0.76
6 [Dietary effects of PUFA omega-3 on lipid peroxidation and antioxidant system in patients with IHD, hyperlipoproteinemia and hypertension]. Vopr Pitan 1994 0.76
7 [Effects of anti-atherosclerosis diet containing omega 3 fatty acids on the lipid spectrum of blood and cell membranes in patients with ischemic heart disease and essential hypertension]. Vopr Pitan 1991 0.76
8 [Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia]. Vopr Pitan 1997 0.76
9 [Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet]. Vopr Pitan 1997 0.76
10 [Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance]. Vopr Pitan 2000 0.76
11 [Immune and metabolic effect of polyunsaturated fatty acids omega 3 in anti-atherosclerotic diet in the treatment of patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan 1994 0.76
12 [Effect of antiatherosclerotic diet, containing polyunsaturated fatty acids of the omega-3 family from flax oil, on fatty acid composition of cell membranes of patients with ischemic heart disease. Hypertensive disease and hyperlipoproteinemia]. Vopr Pitan 1997 0.75
13 The Health and Functioning ICF-60: development and psychometric properties. Clin Psychol Psychother 2014 0.75
14 [The study of the clinical potency of antiatherogenic diet containing flavonoids in cardiovascular patients]. Vopr Pitan 2003 0.75
15 [Effects of polyunsaturated fatty acids of the omega-3 family in the anti-atherosclerotic diet on the activity of lysosomal lipolytic enzymes, mononuclear cells and blood platelets of patients with ischemic heart disease]. Vopr Pitan 1994 0.75
16 [The nutrition analysis of the patients with cardio-vascular diseases]. Vopr Pitan 2005 0.75
17 [Efficacy of the use of a sour milk product enriched with phytosterols in diet therapy of patients with cardiovascular diseases]. Kardiologiia 2008 0.75
18 [Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Vopr Pitan 2002 0.75
19 [Clinical efficiency of using laminaria jam enriched with selenium]. Vopr Pitan 2009 0.75
20 [Anti-atherosclerotic properties of some components of food (a clinico-experimental study)]. Vopr Pitan 1990 0.75
21 [Soybean proteins in correction of coronary risk factors in patients with cardiovascular diseases]. Vopr Pitan 2002 0.75
22 [The study of the association of polymorphism rs5219 gene KCNJ11 with obesity and the risk of type 2 diabetes among residents of the Moscow Region]. Vopr Pitan 2015 0.75
23 [The investigation of influent of antiatherosclerotic diets with inulin on clinical and metabolic parameters in patients with cardiovascular diseases]. Vopr Pitan 2006 0.75
24 [Dietary correction of nutrition status in patients with metabolic syndrome]. Vopr Pitan 2009 0.75
25 [The effect of diets containing omega-3 polyunsaturated fatty acids on biochemical indicators and the fatty acid composition of the cell membranes in patients with ischemic heart disease and hereditary hyperlipidemia]. Vopr Med Khim 1992 0.75
26 [Analysis of modern concepts concerning the role of processed soybean products in diet therapy of patients with cardiovascular diseases]. Vopr Pitan 2000 0.75
27 [Effect of dietotherapy on thrombocyte lysosomal hydrolase activity in patients with hyperlipidemia and ischemic heart disease]. Patol Fiziol Eksp Ter 1987 0.75
28 [Use of phytoestrogens in medicine]. Vopr Pitan 2003 0.75
29 [The effect of diet therapy on the lipolytic activity of the adipose tissue and serum in patients with ischemic heart disease and excessive body weight]. Ter Arkh 1983 0.75
30 [Peculiarity mineralization of osteous tissue of patients wits cardiovascular and gastroenteric pathologic and provision with vitamins and calcium]. Vopr Pitan 2008 0.75
31 [Application of nutritional formulare in the dietotherapy in patients with cardiovascular diseases]. Vopr Pitan 2005 0.75
32 [Dietary fibers in diet therapy]. Vopr Pitan 1998 0.75
33 [Evaluation of the effects of fish and vegetable omega-3 PUFA complex on the erythrocyte fatty acid composition in patients with ischemic heart disease and impaired glucose tolerance]. Vopr Pitan 1999 0.75
34 [Marine fish oil in the prevention and treatment of cardiovascular diseases]. Vestn Ross Akad Med Nauk 1996 0.75
35 [Activity of phospholipases A in the adipose tissue and adipocytes in obesity and ischemic heart disease]. Ter Arkh 1982 0.75
36 [Lipolytic enzymes of platelet and mononuclear cell lysosomes in the pathogenesis of ischemic heart disease pathogenesis]. Vopr Med Khim 1993 0.75
37 [Comparative evaluation of hypolipidemic effects of omega-3 polyunsaturated acids and lipostabil]. Vopr Pitan 1996 0.75
38 [Analysis by bioelectrical impedance of body composition of patients with cardiovascular diseases and obesity]. Vopr Pitan 2005 0.75
39 [Effect of atherosclerotic diet containing polyunsaturated omega-3 fatty acids on level of natural antibodies to prostaglandin F2alpha in patients with ischemic heart disease, hyperlipidemia and hypertension]. Vopr Pitan 1994 0.75
40 [The use of natural phytosterins for correction of abnormalities of lipid metabolism]. Kardiologiia 2011 0.75
41 [The study of polymorphism rs9939609 FTO gene in patients with overweight and obesity]. Vopr Pitan 2011 0.75
42 [Dynamics of the natural antibody level as affected by the biologically active food supplement "Vitol" in patients with hypertensive disease and obesity]. Vopr Pitan 1999 0.75
43 [The effect of a soy protein isolate and sources of polyunsaturated omega-3 fatty acids in an anti-atherosclerotic diet on the lipid spectrum of blood serum and immunological indicators in patients with ischemic heart disease and hypertension]. Vopr Med Khim 1993 0.75
44 [Use of fish oil enriched with carotenoids isolated from sea cucumbers in the diet therapy of patients with hypertension and ischemic heart disease]. Vopr Pitan 2003 0.75
45 [Correction of mineral metabolism impairment with an allowance for seasonal fluctuations in patients with ischemic heart disease and hypertensive disease with overweight]. Vopr Pitan 2001 0.75
46 [Antioxidant level and lipid metabolism in patients with cardiovascular disease]. Vopr Pitan 2007 0.75
47 [Effect of diet therapy on metabolism of prostaglandins in patients with hypertension and obesity]. Vopr Pitan 1998 0.75
48 [Effect of an anti-atherogenic diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension and ischemic heart disease]. Vopr Pitan 2002 0.75
49 [Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates]. Klin Med (Mosk) 2003 0.75
50 [Homocysteine as a coronary risk factor]. Vopr Pitan 2003 0.75
51 [Analysis of regulatory basis for organization of clinical nutrition in medical institutions of the Russian Federation]. Vopr Pitan 2013 0.75
52 [Lipid peroxidation upon the use of omega-3 polyunsaturated fatty acids in the treatment of hypertension and ischemic heart disease]. Vopr Med Khim 1992 0.75
53 [Efficiency of diet therapy containing carbohydrate-protein product enriched with vitamins and minerals in patients with cardiovascular diseases, obesity, and osteopenia]. Vopr Pitan 2008 0.75
54 [The effect of omega-3 polyunsaturated fatty acids on the clinico-biochemical indices and kidney nitrogen-excreting function in patients with chronic kidney failure]. Vopr Pitan 1993 0.75
55 [The study of FTO rs9939609-gene polymorphism in the Sverdlovsk Region]. Vopr Pitan 2012 0.75
56 [Features to improve health care in "dietology" profile in Voronezh Region]. Vopr Pitan 2013 0.75
57 [Vitamin status and bone mineral density at patients with adiposity and the cardiovascular pathology]. Vopr Pitan 2008 0.75
58 [Evaluation of dietary therapy efficiency, based on clinical and biochemical parameters in patients with cardiovascular disease and osteopenia]. Vopr Pitan 2007 0.75
59 [Effects of diet containing polyunsaturated fatty acids omega-3 and different doses of vitamin E on the activity of lipid peroxidation in patients with hypertension]. Vopr Pitan 1995 0.75
60 [Immunoenzyme technique for detection of natural antibodies to bradykinin in cardiovascular diseases]. Klin Lab Diagn 2001 0.75
61 [Effects of biologically active supplements on the antioxidant and vitamin status of patients with hypertension and ischemic heart disease]. Vopr Pitan 2001 0.75
62 [Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity]. Vopr Pitan 2001 0.75
63 [Experience of phytosterols' application in dietetic cardiovascular diseases]. Vopr Pitan 2008 0.75
64 [Clinico-metabolic effects of fish oil in patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension]. Vopr Pitan 1994 0.75
65 [Fat and content of yakutan horse fat tissue]. Vopr Pitan 2005 0.75
66 [Effect of clofibrate on the enzyme activity of liver and adipose tissue lysosomes in the rat in the presence of an unbalanced fatty component in the diet]. Patol Fiziol Eksp Ter 1984 0.75
67 [Cholesterol metabolism in patients with ischemic heart disease with varying supplies of omega-3 polyunsaturated fatty acids]. Vopr Med Khim 1995 0.75
68 [Peculiarities of vitamin status in men and women with cardiovascular disease and obesity]. Vopr Pitan 2012 0.75
69 [Experimental model of the early stages of alimentary obesity in the rat]. Biull Eksp Biol Med 1982 0.75
70 [Thrombocyte lysosomal hydrolase activity in patients with ischemic heart disease, hyperlipidemia and obesity against a background of different diets]. Vopr Pitan 1988 0.75
71 [Comparative study on the effect of antiatherosclerotic diet enriched with polyunsaturated omega-3 fatty acids of plant and animal origin on the level of natural antibodies against catecholamines in patients with cardiovascular diseases]. Vopr Pitan 1998 0.75
72 [The study of soy isoflavone metabolism in patients with cardiovascular diseases]. Vopr Pitan 2002 0.75
73 [Influence of chitosan on clinical-biochemical rates and protein metabolism of patients with cardiovascular diseases]. Vopr Pitan 2008 0.75
74 [Clinical-metabolic evaluation of the effectiveness of the olive oil use in patients with cardiovascular diseases]. Vopr Pitan 2000 0.75
75 [Changes of gastric mucosa in patients with mild form of diabetes mellitus]. Probl Endokrinol (Mosk) 1975 0.75
76 [The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia]. Vopr Pitan 2003 0.75
77 [Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases]. Vopr Pitan 1998 0.75
78 [Effect of neonatal nutrition on the enzyme activity of liver lysosomes, adipocytes and thrombocytes in young and old rats]. Vopr Pitan 1986 0.75
79 [Effect of high-fat load on lysosomal hydrolase activity in the liver, adipose tissue and thrombocytes in rats]. Patol Fiziol Eksp Ter 1986 0.75
80 [The role of the Consultative and Diagnostic Centre "Healthy Nutrition" in the diagnosis and nutritional prevention of non-communicable diseases]. Vopr Pitan 2014 0.75
81 [The study of the peculiarities of metabolism in individuals with rs9939609 polymorphism of FTO gene]. Vopr Pitan 2015 0.75
82 [Dietary fiber influence on vitamins assimilation in patients suffering from cardiovascular diseases and adiposity]. Vopr Pitan 2010 0.75
83 [Effects of antiatherosclerosis diet including soy protein on the dynamics of clinical, biochemical and immunologic indicators in patients with ischemic heart disease and hypertension]. Vopr Pitan 1999 0.75
84 [Determination of natural antibodies to catecholamines in health and disease]. Ter Arkh 1998 0.75
85 [Definite of nutritional status in patients with metabolic syndrome with the use of modern methods of nutrimetabolomica]. Vopr Pitan 2010 0.75
86 [Clinico-biochemical evaluation of the effectiveness of diet therapy in gastroenterologic patients]. Vopr Med Khim 1991 0.75
87 [The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan 2006 0.75
88 [Regional features of obesity-associated gene polymorphism (rs9939609 FTO gene and gene Trp64Arg ADRB3) in Russian population]. Vopr Pitan 2014 0.75
89 [Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases]. Vopr Pitan 1997 0.75
90 [Genetic approaches to nutrition personalization]. Vopr Pitan 2012 0.75
91 [Study of fatty acid composition of cell membranes during the use of soya oil in diet therapy of patients with cardiovascular diseases]. Vopr Pitan 2000 0.75
92 [Effect of an imbalance in the fat component of the diet on the lipolytic activity and stability of the lysosomal membranes of different rat tissues]. Vopr Pitan 1982 0.75
93 [Current views of nutritional therapy]. Klin Med (Mosk) 2009 0.75
94 [Evaluating the effectiveness of dietary management of patients with varying degrees of obesity]. Vopr Pitan 2014 0.75
95 [Study of the state of lipid peroxidation system: antioxidant protection during the use of soy oil in patients with ischemic heart disease and hypertension]. Vopr Pitan 2000 0.75
96 [Biologically active food supplements in comprehensive therapy of patients with ischemic heart disease and hypertension and the background of overweight]. Vopr Pitan 2000 0.75
97 [Energy metabolic in patients with ischemic heart disease before and after heart surgery]. Vopr Pitan 2007 0.75
98 [Study of metabolic and clinical effects of polyunsaturated fatty acids omega-3 from "Eicovit" in patients with ischemic heart disease and familial hyperlipoproteinemia]. Vopr Pitan 1998 0.75
99 [The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. Vopr Pitan 2006 0.75
100 [Using diet therapy based on complex assessment of nutritional status in patient with cardiovascular diseases and obesity]. Vopr Pitan 2007 0.75
101 [Efficiecy of application assessment of grain bread in diettherapy of patients of elderly ages with cardiovascular diseases]. Vopr Pitan 2006 0.75
102 [The use of nutritional antioxidants for the correction of metabolic disorders of cardiovascular patients]. Vopr Pitan 2004 0.75
103 [The study of the association of polymorphism rs659366 gene UCP2 c obesity and type 2 diabetes among residents of the Moscow Region]. Vopr Pitan 2015 0.75
104 [The assessment of clinical efficiency of the diet therapy in cardiosurgery patients]. Vopr Pitan 2007 0.75
105 [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension]. Vopr Pitan 1996 0.75
106 [The homeostatic changes of mineral and trace elements during of year at rheumatoid arthritis]. Vopr Pitan 2006 0.75
107 [Effect of diet enriched with selenium on the psycho-emotional and adaptive capacity of patients with cardiovascular diseases and obesity]. Vopr Pitan 2012 0.75
108 [The study of influence of chitosan on clinical, metabolic and immune parameters in patients with cardiovascular diseases]. Vopr Pitan 2005 0.75
109 [Multilevel study of actual nutrition in the complex analysis of nutritial status of patients with obesity]. Vopr Pitan 2009 0.75
110 [The system of multilevel diagnostics and corrections of nutrition status disorders in the patients with cardiovascular diseases]. Vopr Pitan 2009 0.75